Talk:Oxford–AstraZeneca COVID-19 vaccine

This is the talk page for discussing improvements to the Oxford–AstraZeneca COVID-19 vaccine article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Archives: Index, 1, 2: 30 days

This article is written in British English, which has its own spelling conventions (colour, travelled, centre, defence, artefact, analyse) and some terms that are used in it may be different or absent from other varieties of English. According to the relevant style guide, this should not be changed without broad consensus.

COVID-19 High‑importance

	COVID-19 portal This article is within the scope of WikiProject COVID-19, a project to coordinate efforts to improve all COVID-19-related articles. If you would like to help, you are invited to join and to participate in project discussions.COVID-19Wikipedia:WikiProject COVID-19Template:WikiProject COVID-19COVID-19 articles
High	This article has been rated as High-importance on the project's importance scale.

Medicine High‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
High	This article has been rated as High-importance on the project's importance scale.

Pharmacology High‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
High	This article has been rated as High-importance on the project's importance scale.

University of Oxford High‑importance

	University of Oxford portal This article is within the scope of WikiProject University of Oxford, a collaborative effort to improve the coverage of the University of Oxford on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.University of OxfordWikipedia:WikiProject University of OxfordTemplate:WikiProject University of OxfordUniversity of Oxford articles
High	This article has been rated as High-importance on the project's importance scale.

United Kingdom High‑importance

	United Kingdom portal This article is within the scope of WikiProject United Kingdom, a collaborative effort to improve the coverage of the United Kingdom on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.United KingdomWikipedia:WikiProject United KingdomTemplate:WikiProject United KingdomUnited Kingdom articles
High	This article has been rated as High-importance on the project's importance scale.

England High‑importance

	England portal This article is within the scope of WikiProject England, a collaborative effort to improve the coverage of England on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.EnglandWikipedia:WikiProject EnglandTemplate:WikiProject EnglandEngland-related articles
High	This article has been rated as High-importance on the project's importance scale.

Daily pageviews of this article

A graph should have been displayed here but graphs are temporarily disabled. Until they are enabled again, visit the interactive graph at pageviews.wmcloud.org

The contentious topics procedure applies to this page. This page is related to COVID-19, broadly construed, which has been designated as a contentious topic.

Editors who repeatedly or seriously fail to adhere to the purpose of Wikipedia, any expected standards of behaviour, or any normal editorial process may be blocked or restricted by an administrator. Editors are advised to familiarise themselves with the contentious topics procedures before editing this page.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Oxford–AstraZeneca COVID-19 vaccine.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Nanoparticles?[edit]

Does it use nanoparticles? — Preceding unsigned comment added by 73.38.189.222 (talk) 20:02, 4 November 2022 (UTC)[reply]

This page is not a forum to discuss the topic. It does insofar as a virus is a nanoparticle; viral vector vaccine. Pabsoluterince (talk) 21:59, 4 November 2022 (UTC)[reply]

We're talking about nanoparticle lipids obviously. So, does it use nanoparticles? — Preceding unsigned comment added by 73.38.189.222 (talk) 22:03, 4 November 2022 (UTC)[reply]

The virus it uses as a vector is an adenovirus, which is nonenveloped, meaning it doesn't have a lipid envelope (unlike enveloped viruses, like the coronavirus). Which means the answer is no. 188.159.240.15 (talk) 13:34, 1 May 2024 (UTC)[reply]

Verifiability issues[edit]

It's in category "Withdrawn drugs" but I can't find any sourced content in the article regarding its alleged withdrawal. (t · c) buidhe 04:37, 2 December 2023 (UTC)[reply]

Nothing about it here,[1] and the implication is it's being used in parts of the world where the mRNA ones are tricky to store. Bon courage (talk) 05:20, 2 December 2023 (UTC)[reply]

It has been banned in at least Australia. I'd assume the distinction between banned and withdrawn is to be made, as the manufacturer didn't make this decision. Moreover, I don't know how we treat that category when it has only been withdrawn from some markets (see Nefazodone for a similar instance for withdrawn from some markets and available in others).

That being said, perhaps the category should be reassessed now. Kimen8 (talk) 17:17, 21 March 2024 (UTC)[reply]

Developer[edit]

Should we change the developer from Oxford University to Jenner Institute? Pro translator (talk) 16:41, 21 March 2024 (UTC)[reply]

Apparently withdrawn in EU entirely now?[edit]

https://ec.europa.eu/health/documents/community-register/2024/20240327162288/dec_162288_en.pdf Gigs (talk) 20:28, 6 May 2024 (UTC)[reply]

??[edit]

Reuters says: "AstraZeneca to withdraw COVID-19 vaccine globally, Telegraph reports". Big if true, I guess (?) jp×g 🗯️ 21:24, 7 May 2024 (UTC)[reply]

My problem[edit]

Hi my name is Ranjita Khanal and I from Nepal and me and my mom used covidshield and astrazenica vaccine . After some time I found that i have some blue mark in my body and my mom also have same problem, suddenly my platelets decrease. I went to many doctor, hospital but I don't get any exact reason for all the thing that happened with me.After some time I found one article in BBC news about this vaccine.Then I found that i suffer from many problem because of this vaccine I spent so much money in hospital.Many times I feel suffocate.i am worry about what should I do to make my health good.I don't wanna a blame you or your team but it's all happen because of this vaccine and our county won't help us for this problem. I am waiting for your response,and thank you so much. 2400:1A00:BAA0:55A8:6826:3ADF:1705:98FF (talk) 06:51, 27 May 2024 (UTC)[reply]